Integrin alpha 2b/CD41 Antibody (MWReg30) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-44012
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Mouse
Applications
Flow Cytometry
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Rat IgG1 kappa Clone # MWReg30
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Summary for Integrin alpha 2b/CD41 Antibody (MWReg30) [FITC]
Immunogen
The immunogen for this antibody was CD41.
Clonality
Monoclonal
Host
Rat
Isotype
IgG1 kappa
Applications for Integrin alpha 2b/CD41 Antibody (MWReg30) [FITC]
Application
Recommended Usage
Flow Cytometry
1:10-1:1000
Application Notes
This MWReg30 antibody has been tested by flow cytometric analysis of mouse platelets. This can be used at less than or equal to 0.25 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8cells/test.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS (pH 7.2) with 0.1% gelatin
Preservative
0.09% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Integrin alpha 2b/CD41
Alternate Names
CD41, GP2B, GPIIb, GTA, HPA3, ITGA2b
Gene Symbol
ITGA2B
Additional Integrin alpha 2b/CD41 Products
Product Documents for Integrin alpha 2b/CD41 Antibody (MWReg30) [FITC]
Product Specific Notices for Integrin alpha 2b/CD41 Antibody (MWReg30) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...